Anaheim Bio, a Leiden, Netherlands-based biotechnology company developing treatments for calcium pyrophosphate deposition disease (CPPD), has launched with…
Anaheim Bio, a Leiden, the Netherlands-based preclinical-stage biotechnology company, raised €40M in Series A funding. Backers included Droia Ventures, Frazier Life Sciences, RTW…